Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001061077 | SCV001225808 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003160489 | SCV003912782 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetics and Molecular Pathology, |
RCV003447576 | SCV004175546 | uncertain significance | Thrombocytopenia | 2020-02-10 | criteria provided, single submitter | clinical testing | The FLNA c.7559G>A variant is classified as VUS (PM2, PP3) The FLNA c.7559G>A variant is a single nucleotide change in exon 47 of 48 of the FLNA gene, which is predicted to change the amino acid arginine at position 2520 in the protein to histidine. The variant is rare in population databases (PM2). Computational predictions support a deleterious effect on the gene or gene product (PP3). The variant has been reported in dbSNP (rs781959191). It has not been reported in ClinVar or HGMD. |